Managers / Q1 2022 · view latest →
CIM INVESTMENT MANAGEMENT INC
CIK 0001179791 · 436 SEVENTH AVENUE, KOPPERS BUILDING SUITE 2600, PITTSBURGH, PA, 15219 · 4127652771
Summary
Cim Investment Management Inc reported $334M in U.S.-listed holdings across 299 positions for Q1 2022.
The portfolio is heavily concentrated: Ishares S P 500 Index alone accounts for 22.5% of reported value.
Compared with Q4 2021, the fund opened 1 new position and exited 24.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 61.0% · $204M
- ETP · 34.7% · $116M
- Other · 2.2% · $7M
- REIT · 2.0% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DKNGDraftKings, Inc. | NEW | +25.1K | 25.1K | +$689,000 | $689,000 |
| DKNG1USDDraftKings, Inc. | SOLD OUT | −50.6K | 0 | −$2M | $0 |
| RXNEURRexnord Corp. | SOLD OUT | −6.6K | 0 | −$423,000 | $0 |
| COR1EURCoresite Realty Corp | SOLD OUT | −2.5K | 0 | −$342,000 | $0 |
| SLABSilicon Laboratories Inc | SOLD OUT | −2.3K | 0 | −$328,000 | $0 |
| ASGNEURASGN Incorporated | SOLD OUT | −2.9K | 0 | −$325,000 | $0 |
| LPSNUSDLiveperson Inc. | SOLD OUT | −5.0K | 0 | −$295,000 | $0 |
| 2655787DBlueprint Medicines Corp | SOLD OUT | −2.8K | 0 | −$290,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $375M | 251 | May 19, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $382M | 247 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $369M | 249 | Nov 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $525M | 424 | Aug 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $342M | 249 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $338M | 254 | Nov 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $324M | 255 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $336M | 285 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $310M | 287 | Feb 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $273M | 278 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $294M | 278 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $270M | 267 | May 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $254M | 248 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $225M | 224 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $334M | 299 | May 19, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $652M | 598 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $318M | 299 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $323M | 299 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $318M | 298 | May 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $308M | 285 | Feb 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $263M | 258 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $248M | 252 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $204M | 197 | May 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $253M | 235 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $268M | 315 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $273M | 315 | Aug 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $260M | 309 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $230M | 296 | Feb 5, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.